Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31426 - 31450 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	ARPC4	10093	downregulated	Cisplatin results in decreased expression of ARPC4 mRNA	3p25.3	A22205
Cisplatin	Approved Investigational	ARPC4	10093	upregulated	Cisplatin results in increased expression of ARPC4 mRNA	3p25.3	A22205
Cisplatin	Approved Investigational	ASAP2	8853	downregulated	Cisplatin results in decreased expression of ASAP2 mRNA	2p25.1	A22204
Cisplatin	Approved Investigational	ASTN2	23245	upregulated	Cisplatin results in increased expression of ASTN2 mRNA	9q33.1	A20427
Cisplatin	Approved Investigational	ATAD2	29028	upregulated	Cisplatin results in increased expression of ATAD2 mRNA	8q24.13	A20427
Cisplatin	Approved Investigational	ATF3	467	upregulated	Cisplatin results in increased expression of ATF3 mRNA	1q32.3	A22212 A22211 A20427
Cisplatin	Approved Investigational	ATG3	64422	downregulated	Cisplatin results in decreased expression of ATG3 mRNA	3q13.2	A20660
Cisplatin	Approved Investigational	ATG7	10533	downregulated	Cisplatin results in decreased expression of ATG7 mRNA	3p25.3	A22204
Cisplatin	Approved Investigational	ATM	472	upregulated	Cisplatin results in increased expression of ATM mRNA	11q22.3	A22205
Cisplatin	Approved Investigational	ATP9A	10079	downregulated	Cisplatin results in decreased expression of ATP9A mRNA	20q13.2	A22203
Cisplatin	Approved Investigational	ATXN1	6310	downregulated	Cisplatin results in decreased expression of ATXN1 mRNA	6p22.3	A21499 A20427
Cisplatin	Approved Investigational	AURKB	9212	upregulated	Cisplatin results in increased expression of AURKB mRNA	17p13.1	A20427
Cisplatin	Approved Investigational	AVPI1	60370	upregulated	Cisplatin results in increased expression of AVPI1 mRNA	10q24.2	A22204
Cisplatin	Approved Investigational	AXL	558	upregulated	Cisplatin results in increased expression of AXL mRNA	19q13.2	A22213 A20427
Cisplatin	Approved Investigational	BAD	572	upregulated	Cisplatin results in increased expression of BAD mRNA	11q13.1	A22214
Cisplatin	Approved Investigational	BAG1	573	upregulated	Cisplatin results in increased expression of BAG1 mRNA	9p13.3	A22204
Cisplatin	Approved Investigational	BAK1	578	upregulated	Cisplatin results in increased expression of BAK1 mRNA	6p21.31	A22210
Cisplatin	Approved Investigational	BAX	581	upregulated	Cisplatin results in increased expression of BAX mRNA	19q13.33	A22215 A22216 A22217 A22218 A22219 A22205 A20427
Cisplatin	Approved Investigational	BBC3	27113	upregulated	Cisplatin results in increased expression of BBC3 mRNA	19q13.32	A22220 A22221 A22222 A22212 A20427
Cisplatin	Approved Investigational	BBOX1	8424	downregulated	Cisplatin results in decreased expression of BBOX1 mRNA	11p14.2	A22205
Cisplatin	Approved Investigational	BCAR3	8412	downregulated	Cisplatin results in decreased expression of BCAR3 mRNA	1p22.1	A22204
Cisplatin	Approved Investigational	BCAR3	8412	upregulated	Cisplatin results in increased expression of BCAR3 mRNA	1p22.1	A20427
Cisplatin	Approved Investigational	BCAT1	586	downregulated	Cisplatin results in decreased expression of BCAT1 mRNA	12p12.1	A20427
Cisplatin	Approved Investigational	BCAT2	587	upregulated	Cisplatin results in increased expression of BCAT2 mRNA	19q13.33	A20427
Cisplatin	Approved Investigational	BCKDHB	594	downregulated	Cisplatin results in decreased expression of BCKDHB mRNA	6q14.1	A22203

Displaying entries 31426 - 31450 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability